Imaging Axillary Lymph Nodes in Patients with Newly Diagnosed Breast Cancer

Current Problems in Diagnostic Radiology

Volumn 41, Issue 5, 2012, Pages 149-158

  Rahbar, Habib ^a   Partridge, Savannah C ^a   Javid, Sara H ^a   Lehman, Constance D ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ANATOMICAL CONCEPTS; ASPIRATION BIOPSY; AXILLARY LYMPH NODE; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER PATIENT; CANCER STAGING; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; DIAGNOSTIC ACCURACY; DIFFUSION WEIGHTED IMAGING; ECHOGRAPHY; HUMAN; LYMPH NODE METASTASIS; MAMMOGRAPHY; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PREDICTIVE VALUE; PREOPERATIVE EVALUATION; PROGNOSIS; REVIEW; SENSITIVITY AND SPECIFICITY; SENTINEL LYMPH NODE BIOPSY; ULTRASOUND GUIDED BIOPSY;

AXILLA; BREAST NEOPLASMS; DIFFUSION MAGNETIC RESONANCE IMAGING; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; IMAGE-GUIDED BIOPSY; LYMPH NODE EXCISION; LYMPH NODES; LYMPHATIC METASTASIS; MAGNETIC RESONANCE IMAGING; MAMMOGRAPHY; NEOPLASM STAGING; POSITRON-EMISSION TOMOGRAPHY AND COMPUTED TOMOGRAPHY; RADIOPHARMACEUTICALS; SENTINEL LYMPH NODE BIOPSY; ULTRASONOGRAPHY, MAMMARY;

EID: 84864107462     PISSN: 03630188     EISSN: 15356302     Source Type: Journal    
DOI: 10.1067/j.cpradiol.2011.08.002     Document Type: Review

References (31)

1. Crane-Okada R., Wascher R.A., Elashoff D., et al. Long-term morbidity of sentinel node biopsy versus complete axillary dissection for unilateral breast cancer. Ann Surg Oncol 2008, 15:1996-2005.
2. Purushotham A.D., Upponi S., Klevesath M.B., et al. Morbidity after sentinel lymph node biopsy in primary breast cancer: Results from a randomized controlled trial. J Clin Oncol 2005, 23:4312-4321.
3. Martin R.C., Chagpar A., Scoggins C.R., et al. Clinicopathologic factors associated with false-negative sentinel lymph-node biopsy in breast cancer. Ann Surg 2005, 241:1005-1012. [Discussion 1012-5].
4. Veronesi U., Paganelli G., Viale G., et al. A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer. N Engl J Med 2003, 349:546-553.
5. McMasters K.M., Tuttle T.M., Carlson D.J., et al. Sentinel lymph node biopsy for breast cancer: A suitable alternative to routine axillary dissection in multi-institutional practice when optimal technique is used. J Clin Oncol 2000, 18:2560-2566.
6. Mamounas E.P., Brown A., Anderson S., et al. Sentinel node biopsy after neoadjuvant chemotherapy in breast cancer: Results from National Surgical Adjuvant Breast and Bowel Project protocol B-27. J Clin Oncol 2005, 23:2694-2702.
7. Mainiero M.B. Regional lymph node staging in breast cancer: The increasing role of imaging and ultrasound-guided axillary lymph node fine needle aspiration. Radiol Clin North Am 2010, 48:989-997.
8. Mainiero M.B., Cinelli C.M., Koelliker S.L., et al. Axillary ultrasound and fine-needle aspiration in the preoperative evaluation of the breast cancer patient: An algorithm based on tumor size and lymph node appearance. AJR 2010, 195:1261-1267.
9. Abe H., Schmidt R.A., Sennett C.A., et al. US-guided core needle biopsy of axillary lymph nodes in patients with breast cancer: Why and how to do it. RadioGraphics 2007, 27(suppl 1):S91-S99.
10. Rao R., Lilley L., Andrews V., et al. Axillary staging by percutaneous biopsy: Sensitivity of fine-needle aspiration versus core needle biopsy. Ann Surg Oncol 2009, 16:1170-1175.
11. Holwitt D.M., Swatske M.E., Gillanders W.E., et al. Scientific Presentation Award: The combination of axillary ultrasound and ultrasound-guided biopsy is an accurate predictor of axillary stage in clinically node-negative breast cancer patients. Am J Surg 2008, 196:477-482.
12. Lehman C.D., DeMartini W., Anderson B.O., et al. Indications for breast MRI in the patient with newly diagnosed breast cancer. J Natl Compr Cancer Netw 2009, 7:193-201.
13. Lehman C.D., Gatsonis C., Kuhl C.K., et al. MRI evaluation of the contralateral breast in women with recently diagnosed breast cancer. N Engl J Med 2007, 356:1295-1303.
14. Mortellaro V.E., Marshall J., Singer L., et al. Magnetic resonance imaging for axillary staging in patients with breast cancer. J Magn Reson Imaging 2009, 30:309-312.
15. Baltzer P.A., Dietzel M., Burmeister H.P., et al. Application of MR mammography beyond local staging: Is there a potential to accurately assess axillary lymph nodes?. Evaluation of an extended protocol in an initial prospective study. AJR 2011, 196:W641-W647.
16. Adler L.P., Faulhaber P.F., Schnur K.C., et al. Axillary lymph node metastases: Screening with [F-18]2-deoxy-2-fluoro-d-glucose (FDG) PET. Radiology 1997, 203:323-327.
17. Avril N., Dose J., Jänicke F., et al. Assessment of axillary lymph node involvement in breast cancer patients with positron emission tomography using radiolabeled 2-(fluorine-18)-fluoro-2-deoxy-d-glucose. J Natl Cancer Inst 1996, 88:1204-1209.
18. Greco M., Crippa F., Agresti R., et al. Axillary lymph node staging in breast cancer by 2-fluoro-2-deoxy-d-glucose-positron emission tomography: Clinical evaluation and alternative management. J Natl Cancer Inst 2001, 93:630-635.
19. Wahl R.L., Siegel B.A., Coleman R.E., et al. Prospective multicenter study of axillary nodal staging by positron emission tomography in breast cancer: A report of the staging breast cancer with PET Study Group. J Clin Oncol 2004, 22:277-285.
20. Ueda S., Tsuda H., Asakawa H., et al. Utility of 18F-fluoro-deoxyglucose emission tomography/computed tomography fusion imaging (18F-FDG PET/CT) in combination with ultrasonography for axillary staging in primary breast cancer. BMC Cancer 2008, 8:165.
21. Sharkey F.E., Addington S.L., Fowler L.J., et al. Effects of preoperative chemotherapy on the morphology of resectable breast carcinoma. Mod Pathol 1996, 9:893-900.
22. Javid S., Segara D., Lotfi P., et al. Can breast MRI predict axillary lymph node metastasis in women undergoing neoadjuvant chemotherapy. Ann Surg Oncol 2010, 17:1841-1846.
23. Seenu V., Pavan Kumar M.N., Sharma U., et al. Potential of magnetic resonance spectroscopy to detect metastasis in axillary lymph nodes in breast cancer. Magn Reson Imaging 2005, 23:1005-1010.
24. Memarsadeghi M., Riedl C.C., Kaneider A., et al. Axillary lymph node metastases in patients with breast carcinomas: Assessment with nonenhanced versus uspio-enhanced MR imaging. Radiology 2006, 241:367-377.
25. Michel S.C., Keller T.M., Fröhlich J.M., et al. Preoperative breast cancer staging: MR imaging of the axilla with ultrasmall superparamagnetic iron oxide enhancement. Radiology 2002, 225:527-536.
26. Stadnik T.W., Everaert H., Makkat S., et al. Breast imaging. Preoperative breast cancer staging: Comparison of USPIO-enhanced MR imaging and 18F-fluorodeoxyglucose (FDC) positron emission tomography (PET) imaging for axillary lymph node staging-Initial findings. Eur Radiol 2006, 16:2153-2160.
27. Pandharipande P.V., Harisinghani M.G., Ozanne E.M., et al. Staging MR lymphangiography of the axilla for early breast cancer: Cost-effectiveness analysis. AJR 2008, 191:1308-1319.
28. Yamashita T., Takahara T., Kwee T.C., et al. Diffusion magnetic resonance imaging with gadofosveset trisodium as a negative contrast agent for lymph node metastases assessment. Jpn J Radiol 2011, 29:25-32.
29. Kwee T.C., Takahara T., Luijten P.R., et al. ADC measurements of lymph nodes: Inter- and intra-observer reproducibility study and an overview of the literature. Eur J Radiol 2010, 75:215-220.
30. Sever A.R., Mills P., Jones S.E., et al. Preoperative sentinel node identification with ultrasound using microbubbles in patients with breast cancer. AJR 2011, 196:251-256.
31. Giuliano A.E., Hunt K.K., Ballman K.V., et al. Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: A randomized clinical trial. JAMA 2011, 305:569-575.